Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
Low Level LaserTranscutaneous Vagus Nerve StimulationDiabetic Peripheral Neuropathy
Interventions
DEVICE

Low level laser

Patients in the low level laser group will be irradiated with visible and near-infra-red lasers at a pulsed mode with a frequency of 35 Hz, peak power of 100 mW, and a spot diameter of 5 mm. The 15-minute sessions were performed three times a week for two months, with each laser having a power density of 0.35 mW/cm2 and an energy density of 32.08 J/cm2.

DEVICE

Transcutaneous auricular Vagus nerve stimulation

Patients will receive 30 minutes of transcutaneous vagus nerve stimulation for 2 months, with 5 sessions per week. The antihelix and cymba concha will be sterilized with 75% alcohol, and the electrode will be attached. The device parameters include a wave width of 0.2 ms ± 30%, pulse frequency of 20 Hz, gradually increasing intensity to a tolerable intensity (4-6 mA), and duration of 30 minutes.

Trial Locations (1)

Unknown

out-patient clinic, faculty of physical therapy, Horus university, Damietta

All Listed Sponsors
lead

Horus University

OTHER

NCT07078058 - Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy | Biotech Hunter | Biotech Hunter